Alcohol and Drug Services Study (ADSS), 1996-1999: [United States] (ICPSR 3088)
Assessing the Texas Christian University Drug Screen Instrument with Texas Department of Criminal Justice Inmates, 1999-2000 (ICPSR 3541)
California Drug and Alcohol Treatment Assessment (CALDATA), 1991-1993 (ICPSR 2295)
Criminal Justice Drug Abuse Treatment Studies (CJ-DATS) 2: Organizational Process Improvement Intervention (OPII), 2010-2013 [United States] (ICPSR 35082)
The Criminal Justice Drug Abuse Treatment Studies 2 (CJ-DATS 2) was launched in 2008 with a focus on conducting implementation research in criminal justice settings. NIDA's ultimate goal for CJ-DATS 2 was to identify implementation strategies that maximize the likelihood of sustained delivery of evidence-based practices to improve offender drug abuse and HIV outcomes, and to decrease their risk of incarceration.
The Organizational Process Improvement Intervention (OPII) study (aka Assessment study) focused on implementing assessment and treatment planning processes. Screening and assessment were used to identify substance abuse-related problems and to develop programming to address the problems so identified.
The OPII study engaged corrections and treatment agencies to improve the quality of interagency communication through the effective use of assessment and case planning processes and treatment referrals. Both inter-agency and intra-agency change processes were targeted. A multi-phase implementation protocol was used, wherein agencies engaged in team development, needs assessment, planning, implementation, and sustainability in distinct steps. Early- and delayed-start sites allowed the research team to control for effects of environmental changes within states. The protocol targeted critical communications channels between otherwise often highly segregated correctional and treatment agencies.
Evaluation of the OPII used a multi-site cluster randomized design with multiple measures over the course of the intervention. Clusters consisted of a criminal justice agency and one or more community treatment providers that received referrals from that criminal justice agency. Each of the 9 centers had two clusters (one had three), and each cluster was randomized to an Early-Start or a Delayed-Start condition with multiple measures over the course of the intervention. After randomization, the Early-Start sites began the OPII, while the Delayed-Start sites conducted business as usual, without any additional intervention. After approximately 12 months, or when the Early-Start change team completed the Implementation phase, the Delayed-Start change team began to carry out the protocol.
Throughout the study period different subsets of individuals working at correctional facilities and treatment programs at the study sites were asked to complete surveys. During the Baseline period of the study survey data were collected from correctional staff, correctional directors, treatment staff, treatment directors, correctional executives and treatment executives. These data can be found in (DS1-DS12). The executive respondents provided information at the organizational level for the programs they oversaw (DS5, DS6). Next, Needs Assessments were completed by the change teams and their facilitators (DS13-DS14). The change teams and facilitators also responded to surveys on Process Improvement Planning (DS15-DS19). During the Implementation stage, surveys were administered to select substance abuse treatment programs, change team facilitators, change team members and the immediate supervisors of the change team members (DS20-DS27). Selected correctional and treatment staff members (in the Early-Start sites only) were asked to complete Follow-up surveys at the end of the OPII process (DS28-DS33). Staff members who completed surveys also provided demographic data (DS36-DS41). DS42 is a restricted use version of DS41. Change team members kept track of the time they spent on OPII activities (DS35). Change team success was evaluated by a subset of raters (DS34).
Surveys were administered at 21 study sites and there was a total of over 2,700 survey respondents.
Criminal Justice Drug Abuse Treatment Studies (CJ-DATS): A Comparison of Two Reentry Strategies for Drug Abusing Juvenile Offenders, 2003-2009 [United States] (ICPSR 30143)
Criminal Justice Drug Abuse Treatment Studies (CJ-DATS): HIV/HEPATITIS Prevention for Re-Entering Drug Offenders (ICPSR 29061)
Criminal Justice Drug Abuse Treatment Studies (CJ-DATS): Inmate Pre-Release Assessment (IPASS), 2001 [United States] (ICPSR 29201)
Criminal Justice Drug Abuse Treatment Studies (CJ-DATS): National Criminal Justice Treatment Practices (NCJTP) Survey of Co-occurring Substance Use and Mental Disorder (COD) Treatment Services in Criminal Justice Settings, 2002-2008 (ICPSR 27962)
Criminal Justice Drug Abuse Treatment Studies (CJ-DATS): Performance Indicators for Corrections (PIC), 2002-2006 [United States] (ICPSR 27942)
In 2002, the National Institute on Drug Abuse (NIDA) funded the Criminal Justice Drug Abuse Treatment Studies (CJ-DATS) cooperative agreement. The Institute of Behavioral Research at Texas Christian University (TCU) was one of nine National Research Centers selected to study current drug treatment practices and outcomes in correctional settings and to examine strategies for improving treatment services for drug-involved offenders.
The specific aims of the PIC study were to:
- Cross sectionally test and adapt the TCU CJ-CEST, BOP, and NDRI CAI assessments for use in multiple correctional settings;
- To examine agency and program records of client progress relevant to treatment process; and to
- Revise the assessments as necessary for use in longitudinal assessment protocols and CJ Management Information Systems (MIS).
During the first data collection period, Wave 1, a total of 3,266 inmates were surveyed from research centers based out of Texas Christian University, the University of Delaware, the University of Kentucky, University of California, Los Angeles (UCLA), and the National Development and Research Institute (NDRI). After psychometrics were run and the forms revised slightly, a second administration took place but this time only at two centers (TCU and Delaware). During Wave 2 a total of 1,421 clients participated in the survey.
Criminal Justice Drug Abuse Treatment Studies (CJ-DATS): Step 'N Out, 2002-2006 [United States] (ICPSR 30221)
Criminal Justice Drug Abuse Treatment Studies (CJ-DATS): The Criminal Justice Co-Occurring Disorder Screening Instrument (CJ-CODSI), 2002-2008 [United States] (ICPSR 27963)
Criminal Justice Drug Abuse Treatment Studies (CJ-DATS): Transitional Care Management (TCM), Increasing Aftercare Participation for Parolees, 2004-2008 [United States] (ICPSR 31621)
Drug Abuse Treatment Outcome Study--Adolescent (DATOS-A), 1993-1995: [United States] (ICPSR 3404)
Drug Abuse Treatment Outcome Study (DATOS), 1991-1994: [United States] (ICPSR 2258)
Drug-Abuse Treatment Outcomes Study (DATOS) is a prospective study designed to determine the outcomes of adult drug abuse treatment delivered in typical, stable, community-based programs and to provide comprehensive information on continuing and new questions about the effectiveness of drug abuse treatment for adults currently available in a variety of publicly funded and private programs. The study examined the role of treatment outcomes and program type, client characteristics (including dependence, treatment history, and physical and mental health comorbidities), treatment received (e.g., length and intensity of services provided), therapeutic approaches, provision of aftercare, and research on the components of effective treatment, including factors that engage and retain clients in programs. Four types of programs were included: outpatient methadone (OPM), short-term inpatient (STI), long-term residential (LTR), and outpatient drug-free (ODF). Respondents were sampled from among adults admitted to drug abuse treatment programs in 11 representative U.S. cities during 1991-1993.
Clients entering treatment completed two comprehensive intake interviews (Intake 1 and Intake 2), approximately one week apart. This information is provided in Parts 1 and 2 of the data collection. These interviews were designed to obtain baseline data on drug use and other behaviors, as well as information on background and demographic characteristics, patterns of dependence, living situation and child custody status, education and training, income and expenditures, and HIV risk behaviors, along with assessments of dependence, mental health, physical health, and social functioning. Data on criminal justice status and criminal behavior are reported in Part 5, Illegal Activities Data, and are drawn from the Intake 1 interview. Data reflecting during-treatment progress, including service delivery and client satisfaction, were collected in the one-, three-, and six-month in-treatment interviews (Parts 3, 4, and 8). The 12-Month Post-Treatment Follow-Up Interview (Part 6) replicated many of the intake questions and focused on key behaviors in the year following treatment. Part 7 includes variables for time in treatment and interview availability indicators. The 12-Month Follow-Up Urine Result data (Part 9) provide the results from urine sample tests that were given to a sample of subjects at the time of the 12-Month Follow-Up Interview. Urine specimens were tested for eight categories of drugs (amphetamines, barbiturates, benzodiazepines, cannabinoids, cocaine metabolite, methaqualone, opiates, and phencyclidine). The drugs covered in the study were alcohol, tobacco, marijuana (hashish, THC), hallucinogens or psychedelics such as LSD, mescaline, and PCP, cocaine (including crack), heroin, narcotics or opiates such as morphine, codeine, Demerol, Dilaudid, and Talwin, downers or depressants such as sedatives, barbiturates, and tranquilizers, amphetamines or other stimulants such as speed or diet pills, and other drugs. Part 10 contains data for 1393 clients who were interviewed 5 years post treatment. This part contains many of the same types of questions asked during previous interviews.
Drug Services Research Survey, 1990: [United States] (ICPSR 3393)
Evaluation of the Children at Risk Program in Austin, Texas, Bridgeport, Connecticut, Memphis, Tennessee, Savannah, Georgia, and Seattle, Washington, 1993-1997 (ICPSR 2686)
Harvard School of Public Health College Alcohol Study, 1993 (ICPSR 6577)
Harvard School of Public Health College Alcohol Study, 1997 (ICPSR 3163)
Harvard School of Public Health College Alcohol Study, 1999 (ICPSR 3818)
Harvard School of Public Health College Alcohol Study, 2001 (ICPSR 4291)
National Drug Abuse Treatment Clinical Trials Network (ICPSR 31922)
National Drug Abuse Treatment System Survey, Waves II-IV (ICPSR 4146)
National Drug Abuse Treatment System Survey, Waves V-IX, [United States], 2000-2017 (ICPSR 38420)
The National Drug Abuse Treatment System Survey (NDATSS) is a longitudinal program of research into organizational structures, operating characteristics, and treatment practices of outpatient drug treatment programs in the United States. This is done through interviews with program directors and clinical supervisors. In some publications, this research is referred to as the Outpatient Drug Abuse Treatment Studies (ODATS). Data in this collection include Wave V, Wave VI, Wave VII, Wave VIII, and Wave IX.
NDATSS includes four prior waves of data collection from substance abuse treatment programs surveyed in 1984, 1988, 1990, and 1995. Waves II through IV can be found at ICPSR here.
Wave I is not planned for public release because it had a significantly different sample design than the other waves.
National Evaluation of the Fighting Back Program: General Population Surveys, 1995-1999 (ICPSR 3801)
National Mental Health Services Survey (N-MHSS), 2010 (ICPSR 34945)
The National Mental Health Services Survey (N-MHSS) is an annual survey designed to collect statistical information on the numbers and characteristics of all known mental health treatment facilities within the 50 States, the District of Columbia, and the U.S. territories. In every other year, beginning in 2014, the survey also collects statistical information on the numbers and demographic characteristics of persons served in these treatment facilities as of a specified survey reference date.
The N-MHSS is the only source of national and State-level data on the mental health service delivery system reported by both publicly-operated and privately-operated specialty mental health treatment facilities, including: public psychiatric hospitals; private psychiatric hospitals, non-federal general hospitals with separate psychiatric units; U.S. Department of Veterans Affairs medical centers; residential treatment centers for children; residential treatment centers for adults; outpatient or day treatment or partial hospitalization mental health facilities; and multi-setting (non-hospital) mental health facilities.
The N-MHSS complements the information collected through SAMHSA's survey of substance abuse treatment facilities, the National Survey of Substance Abuse Treatment Services (N-SSATS). Treatment facility Information from the N-MHSS is used to populate the mental health component of SAMHSA's online Behavioral Health Treatment Services Locator.
National Survey of Alcohol, Drug, and Mental Health Problems [Healthcare for Communities], 1997-1998 (ICPSR 3025)
National Survey of Alcohol, Drug, and Mental Health Problems [Healthcare for Communities], 2000-2001 (ICPSR 4165)
National Survey of Substance Abuse Treatment Services (N-SSATS), 2000 (ICPSR 3436)
The National Survey of Substance Abuse Treatment Services (N-SSATS) is designed to collect information from all facilities in the United States, both public and private, that provide substance abuse treatment. N-SSATS provides the mechanism for quantifying the dynamic character and composition of the United States substance abuse treatment delivery system. The objectives of N-SSATS are to collect multipurpose data that can be used to assist the Substance Abuse and Mental Health Services Administration (SAMHSA) and state and local governments in assessing the nature and extent of services provided and in forecasting treatment resource requirements, update SAMHSA's Inventory of Substance Abuse Treatment Services (I-SATS), analyze general treatment services trends, and generate the National Directory of Drug and Alcohol Abuse Treatment Programs and its online equivalent, the Substance Abuse Treatment Facility Locator.
Data are collected on topics including facility operation, services offered (assessment, substance abuse therapy and counseling, testing, transitional, and ancillary), primary focus (substance abuse, mental health, both, general health, other), hotline operation, Opioid Treatment Programs and medication dispensed, languages in which treatment is provided, type of treatment provided, number of clients (total and under age 18), number of beds, types of payment accepted, sliding fee scale, special programs offered, facility accreditation and licensure/certification, and managed care agreements.
National Survey of Substance Abuse Treatment Services (N-SSATS), 2002 (ICPSR 3819)
The National Survey of Substance Abuse Treatment Services (N-SSATS) is designed to collect information from all facilities in the United States, both public and private, that provide substance abuse treatment. N-SSATS provides the mechanism for quantifying the dynamic character and composition of the United States substance abuse treatment delivery system. The objectives of N-SSATS are to collect multipurpose data that can be used to assist the Substance Abuse and Mental Health Services Administration (SAMHSA) and state and local governments in assessing the nature and extent of services provided and in forecasting treatment resource requirements, update SAMHSA's Inventory of Substance Abuse Treatment Services (I-SATS), analyze general treatment services trends, and generate the National Directory of Drug and Alcohol Abuse Treatment Programs and its online equivalent, the Substance Abuse Treatment Facility Locator.
Data are collected on topics including facility operation, services offered (assessment, substance abuse therapy and counseling, pharmacotherapies, testing, transitional, ancillary), primary focus (substance abuse, mental health, both, general health, other), hotline operation, Opioid Treatment Programs and medication dispensed, languages in which treatment is provided, type of treatment provided, number of clients (total and under age 18), number of beds, types of payment accepted, sliding fee scale, special programs offered, facility accreditation and licensure/certification, and managed care agreements.
National Survey of Substance Abuse Treatment Services (N-SSATS), 2003 (ICPSR 4099)
The National Survey of Substance Abuse Treatment Services (N-SSATS) is designed to collect information from all facilities in the United States, both public and private, that provide substance abuse treatment. N-SSATS provides the mechanism for quantifying the dynamic character and composition of the United States substance abuse treatment delivery system. The objectives of N-SSATS are to collect multipurpose data that can be used to assist the Substance Abuse and Mental Health Services Administration (SAMHSA) and state and local governments in assessing the nature and extent of services provided and in forecasting treatment resource requirements, update SAMHSA's Inventory of Substance Abuse Treatment Services (I-SATS), analyze general treatment services trends, and generate the National Directory of Drug and Alcohol Abuse Treatment Programs and its online equivalent, the Substance Abuse Treatment Facility Locator.
Data are collected on topics including facility operation, services offered (assessment, substance abuse therapy and counseling, pharmacotherapies, testing, transitional, ancillary), primary focus (substance abuse, mental health, both, general health, other), hotline operation, Opioid Treatment Programs and medication dispensed, languages in which treatment is provided, type of treatment provided, number of clients (total and under age 18), number of beds, types of payment accepted, sliding fee scale, special programs offered, facility accreditation and licensure/certification, and managed care agreements.
National Survey of Substance Abuse Treatment Services (N-SSATS), 2004 (ICPSR 4256)
The National Survey of Substance Abuse Treatment Services (N-SSATS) is designed to collect information from all facilities in the United States, both public and private, that provide substance abuse treatment. N-SSATS provides the mechanism for quantifying the dynamic character and composition of the United States substance abuse treatment delivery system. The objectives of N-SSATS are to collect multipurpose data that can be used to assist the Substance Abuse and Mental Health Services Administration (SAMHSA) and state and local governments in assessing the nature and extent of services provided and in forecasting treatment resource requirements, update SAMHSA's Inventory of Substance Abuse Treatment Services (I-SATS), analyze general treatment services trends, and generate the National Directory of Drug and Alcohol Abuse Treatment Programs and its online equivalent, the Substance Abuse Treatment Facility Locator.
Data are collected on topics including facility operation, services offered (assessment, substance abuse therapy and counseling, pharmacotherapies, testing, transitional, ancillary), primary focus (substance abuse, mental health, both, general health, other), hotline operation, Opioid Treatment Programs and medication dispensed/prescribed, languages in which treatment is provided, type of treatment provided, number of clients (total and under age 18), number of beds, types of payment accepted, sliding fee scale, special programs offered, facility accreditation and licensure/certification, and managed care agreements.
National Survey of Substance Abuse Treatment Services (N-SSATS), 2005 (ICPSR 4469)
The National Survey of Substance Abuse Treatment Services (N-SSATS) is designed to collect information from all facilities in the United States, both public and private, that provide substance abuse treatment. N-SSATS provides the mechanism for quantifying the dynamic character and composition of the United States substance abuse treatment delivery system. The objectives of N-SSATS are to collect multipurpose data that can be used to assist the Substance Abuse and Mental Health Services Administration (SAMHSA) and state and local governments in assessing the nature and extent of services provided and in forecasting treatment resource requirements, update SAMHSA's Inventory of Substance Abuse Treatment Services (I-SATS), analyze general treatment services trends, and generate the National Directory of Drug and Alcohol Abuse Treatment Programs and its online equivalent, the Substance Abuse Treatment Facility Locator.
Data are collected on topics including facility operation, services offered (assessment, substance abuse therapy and counseling, pharmacotherapies, testing, transitional, ancillary), primary focus (substance abuse, mental health, both, general health, other), hotline operation, Opioid Treatment Programs and medication dispensed/prescribed, languages in which treatment is provided, type of treatment provided, number of clients (total and under age 18), number of beds, types of payment accepted, sliding fee scale, special programs offered, facility accreditation and licensure/certification, and managed care agreements.
National Survey of Substance Abuse Treatment Services (N-SSATS), 2006 (ICPSR 20004)
The National Survey of Substance Abuse Treatment Services (N-SSATS) is designed to collect information from all facilities in the United States, both public and private, that provide substance abuse treatment. N-SSATS provides the mechanism for quantifying the dynamic character and composition of the United States substance abuse treatment delivery system. The objectives of N-SSATS are to collect multipurpose data that can be used to assist the Substance Abuse and Mental Health Services Administration (SAMHSA) and state and local governments in assessing the nature and extent of services provided and in forecasting treatment resource requirements, to update SAMHSA's Inventory of Substance Abuse Treatment Services (I-SATS), to analyze general treatment services trends, and to generate the National Directory of Drug and Alcohol Abuse Treatment Programs and its online equivalent, the Substance Abuse Treatment Facility Locator.
Data are collected on topics including facility operation, services offered (assessment and pre-treatment, substance abuse therapy and counseling, pharmacotherapies, testing, transitional, ancillary), primary focus (substance abuse, mental health, both, general health, and other), hotline operation, Opioid Treatment Programs and medication dispensed/prescribed, languages in which treatment is provided, type of treatment provided, number of clients (total and under age 18), number of beds, types of payment accepted, sliding fee scale, special programs offered, facility accreditation and licensure/certification, and managed care agreements.
National Treatment Improvement Evaluation Study (NTIES), 1992-1997 (ICPSR 2884)
Neuropsychological and Emotional Deficits as Predictors of Correctional Treatment Response in Maryland, 2003-2005 (ICPSR 20349)
Process and Outcome Evaluation of the Residential Substance Abuse Treatment (RSAT) Program in Kyle, Texas, 1993-1995 (ICPSR 2765)
Project on Human Development in Chicago Neighborhoods (PHDCN): Service Use, Wave 2, 1997-2000 (ICPSR 13656)
Services Research Outcomes Study, 1995-1996: [United States] (ICPSR 2691)
The Services Research Outcomes Study (SROS) sought to answer questions about drug treatment efficacy and to describe client characteristics. The study was designed to provide (1) a 1990 cohort of clients to use as baseline for possible changes in treatment outcomes following increased funding to the national treatment system in the 1990s, (2) a before-to-after comparison to measure outcomes of treatment provided in 1990, (3) a follow-up of drug treatment clients five years after treatment to assess the level of sustained improvements in abstinence, and (4) a first look at multiple treatment episodes before and after treatment in a 1990 population.
Part 1 is the Facility Director Interviews and covered topics such as facility staff and organization, revenue and charges, staff hours and compensation, costs, and program characteristics.
Part 2 is the Client Records Abstractions Data, which examined the client records of 2,222 individuals discharged during 1989-1990. Information was abstracted on demographic characteristics of clients, criminal justice involvement, medical conditions, drug history including intravenous drug use, urine test results, drug treatment history, treatment services, and discharge and billing information.
Part 3 consists of the Client Follow-Up Interviews, and was conducted during 1995 and 1996. This part covered the clients' entire life span, with special attention to their behavior and circumstances during the five years before entry to the index (SROS) treatment in 1989-1990 and after leaving that treatment until the time of the interview. Additional questions were asked on patterns of alcohol and drug consumption, criminal activity, employment, health, social support, and other behavior relevant to treatment goals. Drugs included cocaine, crack, heroin, nontreatment methadone, other opiates/synthetics, barbiturates, benzodiazapine, other sedatives/hypnotics, methamphetamines, other amphetamines, marijuana/hash/THC, PCP/LSD, other hallucinogens, inhalants, over-the-counter medications, and alcohol.
Strategic Prevention Framework State Incentive Grant (SPF SIG) National Cross-Site Evaluation [Restricted Use] (ICPSR 28921)
Survey of Inmates in State and Federal Correctional Facilities, 1997 (ICPSR 2598)
Survey of Inmates in State and Federal Correctional Facilities, [United States], 2004 (ICPSR 4572)
Survey of Inmates of Federal Correctional Facilities, 1991 (ICPSR 6037)
Survey of Inmates of State Correctional Facilities, 1979 (ICPSR 7856)
Survey of Inmates of State Correctional Facilities, 1986: [United States] (ICPSR 8711)
Survey of Inmates of State Correctional Facilities, 1991: [United States] (ICPSR 6068)
Survey of Inmates of State Correctional Facilities and Census of State Adult Correctional Facilities, 1974 (ICPSR 7811)
Testing an Occupational Stress Intervention for Harm Reduction Workers in Substance Misuse Settings, Texas, 2024-2025 (ICPSR 39277)
This multi-method study seeks to understand both the factors that contribute to harm reduction workers' occupational stress and those that mitigate it by pursuing the following aims:
Aim 1:
- Understanding occupational stressors and resilience strategies among this population by using semi-structured qualitative focus groups with leaders and workers in harm reduction organizations within Texas.
Aim 2:
- Stress First Aid (SFA) consultants utilized the feedback from the Aim 1 Qualitative Focus Groups to adapt the SFA content for harm reduction. The second aim of the study was to hold a 3-day in person train-the-trainer training on the SFA adapted materials for leaders and workers in harm reduction in Texas. The training was facilitated by SFA consultants. The goal of this initial SFA train-the-trainer session was to test the feasibility and acceptability of adapted SFA/HRW materials and develop cadre of team support champions.
Aim 3:
- A 4-month Field testing of the feasibility, acceptability, and appropriateness of the adapted SFA for leaders and workers in harm reduction. The Field Test included a 2-hour in-person training to introduce SFA concepts and how to use SFA on a day-to-day basis in participant's work life and with coworkers, facilitated by participants in Aim 2 who chose to be champions for the Aim 3 Field Test. Additionally, four virtual monthly learning collaboratives were held as part of the Field Test, designed as monthly touch points to refresh and reinforce the SFA principles and get coaching and feedback around any challenges around using SFA, facilitated by the research study team.
- Evaluating the adapted SFA materials and intervention. Reaction interviews were conducted with 13 participants to supplement the surveys.
Treatment Episode Data Set -- Admissions (TEDS-A) -- Concatenated, 1992 to 2012 (ICPSR 25221)
The Treatment Episode Data Set -- Admissions (TEDS-A) is a national census data system of annual admissions to substance abuse treatment facilities. TEDS-A provides annual data on the number and characteristics of persons admitted to public and private substance abuse treatment programs that receive public funding. The unit of analysis is a treatment admission. TEDS consists of data reported to state substance abuse agencies by the treatment programs, which in turn report it to SAMHSA.
A sister data system, called the Treatment Episode Data Set -- Discharges (TEDS-D), collects data on discharges from substance abuse treatment facilities. The first year of TEDS-A data is 1992, while the first year of TEDS-D is 2006.
TEDS variables that are required to be reported are called the "Minimum Data Set (MDS)", while those that are optional are called the "Supplemental Data Set (SuDS)".
Variables in the MDS include: information on service setting, number of prior treatments, primary source of referral, gender, race, ethnicity, education, employment status, substance(s) abused, route of administration, frequency of use, age at first use, and whether methadone was prescribed in treatment. Supplemental variables include: diagnosis codes, presence of psychiatric problems, living arrangements, source of income, health insurance, expected source of payment, pregnancy and veteran status, marital status, detailed not in labor force codes, detailed criminal justice referral codes, days waiting to enter treatment, and the number of arrests in the 30 days prior to admissions (starting in 2008) .
Substances abused include alcohol, cocaine and crack, marijuana and hashish, heroin, nonprescription methadone, other opiates and synthetics, PCP, other hallucinogens, methamphetamine, other amphetamines, other stimulants, benzodiazepines, other non-benzodiazepine tranquilizers, barbiturates, other non-barbiturate sedatives or hypnotics, inhalants, over-the-counter medications, and other substances.
Created variables include total number of substances reported, intravenous drug use (IDU), and flags for any mention of specific substances.
Treatment Episode Data Set -- Discharges (TEDS-D) -- Concatenated, 2006 to 2011 (ICPSR 30122)
The Treatment Episode Data Set -- Discharges (TEDS-D) is a national census data system of annual discharges from substance abuse treatment facilities. TEDS-D provides annual data on the number and characteristics of persons discharged from public and private substance abuse treatment programs that receive public funding. Data collected both at admission and at discharge is included. The unit of analysis is a treatment discharge. TEDS-D consists of data reported to state substance abuse agencies by the treatment programs, which in turn report it to SAMHSA.
A sister data system, called the Treatment Episode Data Set -- Admissions (TEDS-A), collects data on admissions to substance abuse treatment facilities. The first year of TEDS-A data is 1992, while the first year of TEDS-D is 2006.
TEDS-D variables that are required to be reported are called the "Minimum Data Set (MDS)", while those that are optional are called the "Supplemental Data Set (SuDS)".
Variables unique to TEDS-D, and not part of TEDS-A, are the length of stay, reason for leaving treatment, and service setting at time of discharge. TEDS-D also provides many of the same variables that exist in TEDS-A. This includes information on service setting, number of prior treatments, primary source of referral, gender, race, ethnicity, education, employment status, substance(s) abused, route of administration, frequency of use, age at first use, and whether methadone was prescribed in treatment. Supplemental variables include: diagnosis codes, presence of psychiatric problems, living arrangements, source of income, health insurance, expected source of payment, pregnancy and veteran status, marital status, detailed not in labor force codes, detailed criminal justice referral codes, days waiting to enter treatment, and the number of arrests in the 30 days prior to admissions (starting in 2008).
Substances abused include alcohol, cocaine and crack, marijuana and hashish, heroin, nonprescription methadone, other opiates and synthetics, PCP, other hallucinogens, methamphetamine, other amphetamines, other stimulants, benzodiazepines, other non-benzodiazepine tranquilizers, barbiturates, other non-barbiturate sedatives or hypnotics, inhalants, over-the-counter medications, and other substances.
Created variables include total number of substances reported, intravenous drug use (IDU), and flags for any mention of specific substances.